Abstract
CASE
A 43-year-old female with systemic lupus erythematosus (SLE) was admitted with fever and shortness of breath 1 month after aortic valve replacement. A diagnostic workup including chemistries, complete blood count, blood cultures, chest x-ray, and 2-D echocardiogram was performed to determine the etiology of her symptoms and differentiate between acute bacterial endocarditis and Libman–Sacks endocarditis.
DISCUSSION
By utilizing Duke’s criteria, antiphospholipid antibodies, and serial echocardiography, we were able to make a diagnosis of Libman–Sacks endocarditis. The patient was successfully treated for Libman–Sacks endocarditis and recovered uneventfully.
CONCLUSION
This case highlights the challenges of making the correct diagnosis when 2 disease processes present with similar findings.
This is a preview of subscription content, log in via an institution to check access.
References
Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701–7.
Hojnik M, et al. Heart involvement (Libman Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579–87.
Chartash EK, et al. Aortic insufficiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med. 1989;86:407–12.
Moyssakis I, et al. Libman–Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120:636–42.
Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipds antibodies. J Am Coll Cardiol. 1992;20:1127–34.
Roldan CA, Shivley BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424–30.
Farzaneh-far A, Roman MJ, Lockshin MD, et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum. 2006;54:3918–25.
Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633.
Asherson R, Cervera R. Antiphospholipid Antibodies and the Heart. Circulation. 1991;84(2):920–22.
Barnes EV, Narain S, Naranjo A, et al. High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk. Lupus. 2005;14:576–82.
Leszcerynski P, et al. Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies. Clin Rheumatol. 2003;22(6):405–8.
Amoroso A, Cacciapaglia F, De Castro S, et al. The adjunctive role of antiphopholpid antibodies in systemic lupus erythematosus cardiac involvement. Clin Exp Rheumatol. 2006;24(3):286–94.
Perez-Villa F, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term follow up study. Arthritis Rheum. 2005;53(3):460–67.
Paran D, Caspi D, Levartovsky D, et al. Cardiac dysfunction in patients with systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. 2007;66:506–10.
Roland CA. Valvular disease associated with systemic illness. Cardiol Clin. 1998;16(3):531–50.
Gonzales-Juanatey C. Libman Sacks endocarditis and primary antiphospholipid syndrome. J Heart Valve Dis. 2005;14:700–2.
Acknowledgments
The author would like to thank Philip Sack MD, Cardiology Fellow, Section of General Cardiology, Tulane University Medical School, for his assistance with the echocardiographic images.
Conflict of Interest
None disclosed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ménard, G.E. Establishing the Diagnosis of Libman–Sacks Endocarditis in Systemic Lupus Erythematosus. J GEN INTERN MED 23, 883–886 (2008). https://doi.org/10.1007/s11606-008-0627-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-008-0627-8